CD1d-glycolipid tetramers: A new tool to monitor natural killer T cells in health and disease - PubMed (original) (raw)

Comment

CD1d-glycolipid tetramers: A new tool to monitor natural killer T cells in health and disease

H R MacDonald. J Exp Med. 2000.

No abstract available

PubMed Disclaimer

Figures

Figure 1

Speculative model of thymic NK T cell development. The model attempts to account for the unusual coreceptor expression pattern of CD1d-dependent NK T cells as a byproduct of mainstream T cell development. The hatched line represents a putative stage where CD4+CD8+ thymocytes become irreversibly committed to the CD4 or CD8 lineage.

Comment on

• Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers.
  Matsuda JL, Naidenko OV, Gapin L, Nakayama T, Taniguchi M, Wang CR, Koezuka Y, Kronenberg M. Matsuda JL, et al. J Exp Med. 2000 Sep 4;192(5):741-54. doi: 10.1084/jem.192.5.741. J Exp Med. 2000. PMID: 10974039 Free PMC article.

Similar articles

• Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers.
  Matsuda JL, Naidenko OV, Gapin L, Nakayama T, Taniguchi M, Wang CR, Koezuka Y, Kronenberg M. Matsuda JL, et al. J Exp Med. 2000 Sep 4;192(5):741-54. doi: 10.1084/jem.192.5.741. J Exp Med. 2000. PMID: 10974039 Free PMC article.
• Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining.
  Gumperz JE, Miyake S, Yamamura T, Brenner MB. Gumperz JE, et al. J Exp Med. 2002 Mar 4;195(5):625-36. doi: 10.1084/jem.20011786. J Exp Med. 2002. PMID: 11877485 Free PMC article.
• T cell receptors get back to basics.
  Jones EY, Salio M, Cerundolo V. Jones EY, et al. Nat Immunol. 2007 Oct;8(10):1033-5. doi: 10.1038/ni1007-1033. Nat Immunol. 2007. PMID: 17878911 No abstract available.
• The in vivo response of invariant natural killer T cells to glycolipid antigens.
  Parekh VV, Lalani S, Van Kaer L. Parekh VV, et al. Int Rev Immunol. 2007 Jan-Apr;26(1-2):31-48. doi: 10.1080/08830180601070179. Int Rev Immunol. 2007. PMID: 17454263 Review.
• The immunoregulatory role of CD1d-restricted natural killer T cells in disease.
  van der Vliet HJ, Molling JW, von Blomberg BM, Nishi N, Kölgen W, van den Eertwegh AJ, Pinedo HM, Giaccone G, Scheper RJ. van der Vliet HJ, et al. Clin Immunol. 2004 Jul;112(1):8-23. doi: 10.1016/j.clim.2004.03.003. Clin Immunol. 2004. PMID: 15207777 Review.

Cited by

• Natural killer T cells in allergic asthma: implications for the development of novel immunotherapeutical strategies.
  Gutiérrez-Vera C, García-Betancourt R, Palacios PA, Müller M, Montero DA, Verdugo C, Ortiz F, Simon F, Kalergis AM, González PA, Saavedra-Avila NA, Porcelli SA, Carreño LJ. Gutiérrez-Vera C, et al. Front Immunol. 2024 Apr 2;15:1364774. doi: 10.3389/fimmu.2024.1364774. eCollection 2024. Front Immunol. 2024. PMID: 38629075 Free PMC article. Review.
• Renal double negative T cells: unconventional cells in search of a function.
  Nemenoff RA, Kleczko EK, Hopp K. Nemenoff RA, et al. Ann Transl Med. 2019 Dec;7(Suppl 8):S342. doi: 10.21037/atm.2019.09.107. Ann Transl Med. 2019. PMID: 32016060 Free PMC article. No abstract available.
• Natural killer T cells in multiple sclerosis and its animal model, experimental autoimmune encephalomyelitis.
  Van Kaer L, Wu L, Parekh VV. Van Kaer L, et al. Immunology. 2015 Sep;146(1):1-10. doi: 10.1111/imm.12485. Epub 2015 Jun 22. Immunology. 2015. PMID: 26032048 Free PMC article. Review.
• Biocompatible Gold Nanorod Conjugates for Preclinical Biomedical Research.
  Liopo A, Conjusteau A, Tsyboulski D, Ermolinsky B, Kazansky A, Oraevsky A. Liopo A, et al. J Nanomed Nanotechnol. 2012 Aug 3;S2:001. doi: 10.4172/2157-7439.S2-001. J Nanomed Nanotechnol. 2012. PMID: 23264890 Free PMC article.
• Activation of invariant natural killer T cells by lipid excess promotes tissue inflammation, insulin resistance, and hepatic steatosis in obese mice.
  Wu L, Parekh VV, Gabriel CL, Bracy DP, Marks-Shulman PA, Tamboli RA, Kim S, Mendez-Fernandez YV, Besra GS, Lomenick JP, Williams B, Wasserman DH, Van Kaer L. Wu L, et al. Proc Natl Acad Sci U S A. 2012 May 8;109(19):E1143-52. doi: 10.1073/pnas.1200498109. Epub 2012 Apr 9. Proc Natl Acad Sci U S A. 2012. PMID: 22493234 Free PMC article.

References

1. 1. Bendelac A., Rivera M.N., Park S.H., Roark J.H. Mouse CD1-specific NK1 T cellsdevelopment, specificity, and function. Annu. Rev. Immunol. 1997;15:535–562. - PubMed
2. 1. MacDonald H.R. NK1.1+ T cell receptor-α/β+ cellsnew clues to their origin, specificity, and function. J. Exp. Med. 1995;182:633–638. - PMC - PubMed
3. 1. Kawano T., Cui J., Koezuka Y., Toura I., Kaneko Y., Motoki K., Ueno H., Nakagawa R., Sato H., Kondo E. CD1d-restricted and TCR-mediated activation of Vα14 NKT cells by glycosylceramides. Science. 1997;278:1626–1629. - PubMed
4. 1. Yoshimoto T., Paul W.E. CD4pos, NK1.1pos T cells promptly produce interleukin 4 in response to in vivo challenge with anti-CD3. J. Exp. Med. 1994;179:1285–1295. - PMC - PubMed
5. 1. Eberl G., Lees R., Smiley S.T., Taniguchi M., Grusby M.J., MacDonald H.R. Tissue-specific segregation of CD1d-dependent and CD1d-independent NK T cells. J. Immunol. 1999;162:6410–6419. - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Europe PubMed Central
  • Ovid Technologies, Inc.
  • PubMed Central
  • Silverchair Information Systems

• Other Literature Sources

  • The Lens - Patent Citations